Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells. - Aoki T; Kobayashi M; Okoshi M; Yamaguchi M; Okura H; Sasaki S; Sasako Y; Kira S; Chang YH; Yakushiji-Kaminatsui N; Sharif J; Matsuda M; et al. (Stem cell research & therapy, 2026)